These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-000330-36 Phase 3 Randomized Study of TLK286 (Telcyta?) versus Gefitinib (Iressa®) as Third-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer not-yet-due
Not reported 2006-000366-36 Phase 3 randomized study of TLK286 (Telcyta™) in combination with liposomal doxorubicin (Doxil®/Caelyx®) versus liposomal doxorubicin (Doxil®/Caelyx®) as second-line therapy in platinum refractory or ... 2008-06-30 due-trials